Etoricoxib-induced fixed drug eruption: Report of seven cases
BACKGROUNDFixed drug eruption (FDE) is a characteristic form of intraepidermal CD8+ T cell-mediated drug reaction, with repeated appearance of isolated or multiple skin lesions in the same location after receiving the offending drug. Non-steroidal anti-inflammatory drugs (NSAID) are the most common...
Saved in:
Published in | Contact dermatitis Vol. 84; no. 3; pp. 192 - 195 |
---|---|
Main Authors | , , , , |
Format | Report |
Language | English |
Published |
01.03.2021
|
Online Access | Get full text |
Cover
Loading…
Abstract | BACKGROUNDFixed drug eruption (FDE) is a characteristic form of intraepidermal CD8+ T cell-mediated drug reaction, with repeated appearance of isolated or multiple skin lesions in the same location after receiving the offending drug. Non-steroidal anti-inflammatory drugs (NSAID) are the most common cause. Selective inhibitors of inducible cyclooxygenase 2 (COX-2) provoke a lesser degree of allergic or idiosyncratic adverse reactions than conventional NSAID, but they can cause skin reactions of variable severity. OBJECTIVEEtoricoxib has been related to a variety of unusual skin reactions, including several reports of FDE. METHODSWe perfomed epicutaneous test to diagnose patients with suspected etoricoxib fixe drug rash due to clinical features and reproducibility on at least two occasions. RESULTSWe present seven new cases of etoricoxib-induced fixed drug eruption, with a diagnosis based on clinical presentation. This diagnosis was confirmed by an etoricoxib-positive lesional patch test in six cases and by a positive low-dose oral challenge in the other one. Two patients showed negative patch tests with celecoxib (10% in pet.) on the residual lesions, and oral tolerance was confirmed in one. CONCLUSIONTo our knowledge, this is the largest series on FDE induced by etoricoxib reported to date. |
---|---|
AbstractList | BACKGROUNDFixed drug eruption (FDE) is a characteristic form of intraepidermal CD8+ T cell-mediated drug reaction, with repeated appearance of isolated or multiple skin lesions in the same location after receiving the offending drug. Non-steroidal anti-inflammatory drugs (NSAID) are the most common cause. Selective inhibitors of inducible cyclooxygenase 2 (COX-2) provoke a lesser degree of allergic or idiosyncratic adverse reactions than conventional NSAID, but they can cause skin reactions of variable severity. OBJECTIVEEtoricoxib has been related to a variety of unusual skin reactions, including several reports of FDE. METHODSWe perfomed epicutaneous test to diagnose patients with suspected etoricoxib fixe drug rash due to clinical features and reproducibility on at least two occasions. RESULTSWe present seven new cases of etoricoxib-induced fixed drug eruption, with a diagnosis based on clinical presentation. This diagnosis was confirmed by an etoricoxib-positive lesional patch test in six cases and by a positive low-dose oral challenge in the other one. Two patients showed negative patch tests with celecoxib (10% in pet.) on the residual lesions, and oral tolerance was confirmed in one. CONCLUSIONTo our knowledge, this is the largest series on FDE induced by etoricoxib reported to date. |
Author | Galán Gimeno, Cristina Jáuregui Presa, Ignacio Gamboa Setién, Pedro M Martínez Antón, Maria Dolores Sánchez de Vicente, Javier |
Author_xml | – sequence: 1 givenname: Maria Dolores surname: Martínez Antón fullname: Martínez Antón, Maria Dolores – sequence: 2 givenname: Cristina surname: Galán Gimeno fullname: Galán Gimeno, Cristina – sequence: 3 givenname: Javier surname: Sánchez de Vicente fullname: Sánchez de Vicente, Javier – sequence: 4 givenname: Ignacio surname: Jáuregui Presa fullname: Jáuregui Presa, Ignacio – sequence: 5 givenname: Pedro M surname: Gamboa Setién fullname: Gamboa Setién, Pedro M |
BookMark | eNqVirsKwjAUQIMoaNXBP8jo0pr0EVrBSRRncS81uZVIza25jfj5OvgDnuGc5URs7NABYyspEvllo9EkMlNFNWIzqYSIRZGpKYuI7kJIlafljO0OA3qr8W2vsXUmaDC8te-vjQ83Dj70g0W35Wfo0Q8cW07wAsd1Q0ALNmmbjmD565ytj4fL_hT3Hp8BaKgfljR0XeMAA9VpnuaiUmVeZH-sHxyXQUE |
ContentType | Report |
DBID | 7X8 |
DOI | 10.1111/cod.13659 |
DatabaseName | MEDLINE - Academic |
DatabaseTitle | MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1600-0536 |
EndPage | 195 |
Genre | Commentary Report Editorial Case Study |
GroupedDBID | --- .3N .GA 05W 0R~ 10A 1CY 1OB 1OC 29F 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 6J9 702 7PT 7X8 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AAXRX AAZKR ABCQN ABCUV ABDBF ABHFT ABJNI ABPVW ABQWH ABXGK ACAHQ ACCFJ ACCZN ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACXBN ACXQS ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFZJQ AHBTC AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ATUGU AZBYB AZVAB BAFTC BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EBC EBD EBS EMB EMK EMOBN ESX EX3 F00 F01 F04 F5P FUBAC G-S G.N GODZA H.X HGLYW HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LMP LOXES LP6 LP7 LUTES LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 R.K ROL RX1 SUPJJ SV3 TEORI TUS UB1 V8K V9Y W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 YOC ZZTAW ~IA ~WT |
ID | FETCH-proquest_miscellaneous_24240968453 |
IngestDate | Fri Aug 16 01:53:18 EDT 2024 |
IsPeerReviewed | false |
IsScholarly | false |
Issue | 3 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-proquest_miscellaneous_24240968453 |
Notes | ObjectType-Commentary-1 ObjectType-Case Study-4 content type line 59 SourceType-Reports-1 ObjectType-Report-3 ObjectType-Editorial-2 |
PQID | 2424096845 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_2424096845 |
PublicationCentury | 2000 |
PublicationDate | 20210301 |
PublicationDateYYYYMMDD | 2021-03-01 |
PublicationDate_xml | – month: 03 year: 2021 text: 20210301 day: 01 |
PublicationDecade | 2020 |
PublicationTitle | Contact dermatitis |
PublicationYear | 2021 |
SSID | ssj0016428 |
Score | 3.3128536 |
Snippet | BACKGROUNDFixed drug eruption (FDE) is a characteristic form of intraepidermal CD8+ T cell-mediated drug reaction, with repeated appearance of isolated or... |
SourceID | proquest |
SourceType | Aggregation Database |
StartPage | 192 |
Title | Etoricoxib-induced fixed drug eruption: Report of seven cases |
URI | https://search.proquest.com/docview/2424096845 |
Volume | 84 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dS8MwEA86RXzzE7-p4IMwOuzS1tZH3ZeyTdBN9laSNh0FyWRbYeyv9y5pu4ETP15CG0IKvcvdL8nv7gi5Eq7tMS-umpRHjmlX49j0aOyanLoiZjwK_RCDkztdt9W3nwbOYHGYo6JLprwSzlfGlfxHqtAHcsUo2T9ItpgUOuAZ5AstSBjaX8m4rjJ8jGYJN2FrneJVfpzMoI3G6bAsxulHTt3QOBuR4QRTNpVDcF6TZWCKWaowXDISGsMmBdbGRAPqOr0mxRyTDeDLPZVZpE_CAITDpn_BRWyydzXekuUm1g7Qh7HKmMjCCbxmQ0Bn5vDR8luCNFF9oM_QVxfUHj0QK0ikiWKMKLj7OJQs1Byy_NCiusTaqghtaF2MaHd08pPcEuticZnG0SWzaul6eZmHtnRZzm-Mfwh-B7l7_sLD5bf63eeg0W-3g1590FsnG9Vb30EWYO2lyDhm4XYsS0CFhK9isi-uWuGP3g7Z1ALcJWtC7pGtTsaI2CcrdMBQOmCgDhi5DtwZegJjFBtKAwylAQfkulHvPbTM_KsBLHu8y2FSjNJJgFE9sPv0bIcekpIcSXFEDNdmAiAY9Xjk26HjejcxrEXb4Yxx6kTuMbn8cbqTX4w5JdsLoZ6R0nScinPAZlN-of7mJ4gEQrY |
link.rule.ids | 786,790,4509,27958 |
linkProvider | Wiley-Blackwell |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Etoricoxib-induced+fixed+drug+eruption%3A+Report+of+seven+cases&rft.jtitle=Contact+dermatitis&rft.au=Mart%C3%ADnez+Ant%C3%B3n%2C+Maria+Dolores&rft.au=Gal%C3%A1n+Gimeno%2C+Cristina&rft.au=S%C3%A1nchez+de+Vicente%2C+Javier&rft.au=J%C3%A1uregui+Presa%2C+Ignacio&rft.date=2021-03-01&rft.eissn=1600-0536&rft.volume=84&rft.issue=3&rft.spage=192&rft.epage=195&rft_id=info:doi/10.1111%2Fcod.13659&rft.externalDBID=NO_FULL_TEXT |